azomycin has been researched along with Angiogenesis, Pathologic in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 19 (57.58) | 29.6817 |
| 2010's | 12 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krohn, KA; Rajendran, JG | 1 |
| Baker, LCJ; Bhide, SA; Box, C; d'Arcy, JA; Dunlop, A; Eccles, SA; Harrington, KJ; Hopkinson, G; Koh, DM; Leach, MO; Mcquaid, D; Newbold, KL; Nutting, CM; Panek, R; Richardson, C; Riddell, AM; Robinson, SP; Schmidt, MA; Welsh, L; Wong, KH | 1 |
| Bayin, NS; Placantonakis, DG | 1 |
| Hu, M; Kong, L; Mu, D; Xing, L; Yang, G; Yang, W; Yu, J | 1 |
| Gao, M; Huang, D; Jiang, C; Lou, B; Lu, X; Ni, Y; Peng, F; Ren, K; Wang, X; Yang, A; Yao, N; Zhang, J | 1 |
| Crukley, C; Desjardins, L; Hadway, J; Lee, TY; Morrison, L; Stewart, E; Wang, Y | 1 |
| Krohn, KA; Link, JM; Mason, RP | 1 |
| Hirota, M; Kikuta, K; Masamune, A; Satoh, K; Shimosegawa, T; Watanabe, T | 1 |
| Batmunkh, E; Hori, H; Miyake, K; Nagasawa, H; Nishioka, M; Shimada, M; Sugimoto, K; Uto, Y | 1 |
| Boerman, OC; Bussink, J; Kaanders, JH; Laverman, P; Oyen, WJ; Troost, EG | 1 |
| Cui, P; Dai, M; Han, J; Li, H; Liu, Q; Xiu, R; Yu, M; Zhang, J | 1 |
| Boutrid, H; Cebulla, CM; Feuer, WJ; Jockovich, ME; Lampidis, TJ; Murray, TG; Piña, Y | 1 |
| De Raeve, H; Handisides, DR; Hart, CP; Hu, J; Liu, Q; Menu, E; Sun, JD; Van Camp, B; Van Valckenborgh, E; Vande Broek, I; Vanderkerken, K | 1 |
| Baumann, M; Dörfler, A; Eicheler, W; Hering, S; Leichtner, T; Thames, H; Yaromina, A; Zhou, X; Zips, D | 1 |
| Chitneni, SK; Dewhirst, MW; Palmer, GM; Zalutsky, MR | 1 |
| Betts, G; Bonington, SC; Buckley, DL; Donaldson, SB; Homer, JJ; Kershaw, LE; Slevin, NJ; Valentine, H; West, CM | 1 |
| Bussink, J; Kaanders, JH; Lok, J; Rademakers, SE; van der Kogel, AJ | 1 |
| Chen, FH; Chiang, CS; Fu, SY; Hong, JH; Jung, SM; Lee, CC; Tsai, CS; Wang, CC; Wen, CJ | 1 |
| Ahluwalia, D; Ammons, WS; Curd, JG; Duan, JX; Ferraro, D; Hart, CP; Liu, Q; Matteucci, MD; Sun, JD; Wang, J; Wang, Y | 1 |
| Balm, AJ; Begg, AC; Blijweert, E; Blommestijn, G; Delaere, P; Haustermans, KM; Hoebers, FJ; Hofland, I; Janssen, HL; Raleigh, JA; Sciot, R; Semenza, GL; Sprong, D; van Velthuysen, ML; Varia, MA | 1 |
| Ashino, H; Hazato, T; Hori, H; Inayama, S; Nagasawa, H; Shimamura, M; Uto, Y; Yamamoto, Y | 1 |
| Décorps, M; Farion, R; Peters, JP; Rémy, C; Rijken, PF; Van der Kogel, AJ; Van der Sanden, BP; Zoula, S | 1 |
| Frischer, JS; Holash, J; Huang, J; Kadenhe-Chiwishe, A; Kandel, JJ; Kim, ES; Lee, A; New, T; Pollyea, DA; Serur, A; Yamashiro, DJ; Yancopoulos, GD; Yokoi, A | 1 |
| Daley, FM; Hoskin, PJ; Saunders, MI; Sibtain, A; Wilson, GD | 1 |
| Fitzmaurice, RJ; Lunt, SJ; Stratford, IJ; Telfer, BA; Williams, KJ | 1 |
| Asosingh, K; De Raeve, H; de Ridder, M; Storme, GA; Van Camp, B; Van Riet, I; Vanderkerken, K; Willems, A | 1 |
| Kaanders, JH; Marres, HA; Peters, JP; Rijken, PF; van der Kogel, AJ; Wijffels, KI | 1 |
| Beck, R; Haubner, R; Johnson, TD; Machulla, HJ; Picchio, M; Piert, M; Reischl, G; Schwaiger, M; Seidl, S; Wester, HJ | 1 |
| Bijnens, AP; Cleutjens, JP; Corvol, P; Daemen, MJ; Gasc, JM; Groeneweg, M; Kisters, N; Sluimer, JC; Sollewijn Gelpke, MD; van den Akker, LH; van Wanroij, JL; Wouters, BG | 1 |
| Mayr, M; Sidibe, A; Zampetaki, A | 1 |
| Eschmann, SM; Langen, KJ | 1 |
| Adams, GE; Horsman, MR; Khalil, AA; Overgaard, J; Steinberg, F; Stratford, IJ; Streffer, C; Wood, PJ | 1 |
| Corpechot, C; Galy, B; Housset, C; Poupon, R; Raleigh, J; Rosmorduc, O; Sebbagh, N; Wendum, D | 1 |
3 review(s) available for azomycin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Imaging hypoxia and angiogenesis in tumors.
Topics: Cell Hypoxia; Humans; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Radionuclide Imaging | 2005 |
Molecular imaging of hypoxia.
Topics: Animals; Cell Hypoxia; Coordination Complexes; Electron Spin Resonance Spectroscopy; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Organometallic Compounds; Oximetry; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones | 2008 |
Molecular imaging of hypoxia.
Topics: Humans; Hypoxia; Misonidazole; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2011 |
1 trial(s) available for azomycin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Hypoxia imaging with 18F-fluoroerythronitroimidazole integrated PET/CT and immunohistochemical studies in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Glucose; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neovascularization, Pathologic; Nitroimidazoles; Positron-Emission Tomography; Survival Analysis; Tomography, X-Ray Computed | 2013 |
29 other study(ies) available for azomycin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI.
Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Contrast Media; Female; Head and Neck Neoplasms; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Mice; Neovascularization, Pathologic; Nitroimidazoles; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |
Evaluation of Vascularity, Blood Perfusion, and Oxygen Tension in Tumor Xenografts with Fluorescent Microscopy.
Topics: Animals; Disease Models, Animal; Fluorescent Antibody Technique; Heterografts; Humans; Hypoxia; Mice; Microscopy, Fluorescence; Neoplasm Staging; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Oxygen | 2018 |
Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mammary Neoplasms, Animal; Neovascularization, Pathologic; Nitroimidazoles; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction; Stilbenes | 2015 |
Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Liver Neoplasms; Male; Neovascularization, Pathologic; Nitroimidazoles; Oxygen Consumption; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits | 2017 |
Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer.
Topics: Animals; Cell Hypoxia; Cell Movement; Cell Proliferation; Culture Media, Conditioned; Fibrosis; Humans; Neovascularization, Pathologic; Nitroimidazoles; Pancreatic Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Liver Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous | 2008 |
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-gluco-RGD autoradiography.
Topics: Animals; Diagnostic Imaging; Glucosides; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Radiopharmaceuticals; Research Design | 2008 |
Effect of artificial oxygen carrier with chemotherapy on tumor hypoxia and neovascularization.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cricetinae; HeLa Cells; Hemoglobins; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mesocricetus; Microvessels; Neoplasms, Experimental; Neovascularization, Pathologic; Nitroimidazoles; Oxygen; Oxygen Inhalation Therapy; Polyethylene Glycols; Tumor Burden | 2008 |
Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carboplatin; Disease Models, Animal; Hypoxia; Mice; Mice, Transgenic; Microscopy, Confocal; Neovascularization, Pathologic; Nitroimidazoles; Pregnadienediols; Retinal Neoplasms; Retinoblastoma | 2009 |
Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug.
Topics: Animals; Apoptosis; Blotting, Western; Bone Marrow; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Humans; Hypoxia; Male; Mice; Mice, Inbred C57BL; Multiple Myeloma; Neovascularization, Pathologic; Nitroimidazoles; Oxygen; Phosphoramide Mustards; Prodrugs; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2010 |
Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation.
Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Confidence Intervals; Disease Models, Animal; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology; Transplantation, Heterologous; Tumor Microenvironment | 2010 |
Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study.
Topics: Aged; Algorithms; Carcinoma, Squamous Cell; Cell Hypoxia; Coloring Agents; Contrast Media; Female; Head and Neck Neoplasms; Humans; Kinetics; Magnetic Resonance Imaging; Male; Middle Aged; Models, Biological; Neoplasm Proteins; Neovascularization, Pathologic; Nitroimidazoles; Pilot Projects; Real-Time Polymerase Chain Reaction; Tumor Burden; Vascular Endothelial Growth Factor A | 2011 |
Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Cycle Proteins; Cell Hypoxia; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Monocarboxylic Acid Transporters; Muscle Proteins; Neoplasm Staging; Neovascularization, Pathologic; Nitroimidazoles; Oncogene Proteins; Protein Transport; Proteins | 2011 |
Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
Topics: Angiogenesis Inhibitors; Animals; Bone Marrow Transplantation; Cell Aggregation; Cell Hypoxia; Cell Line, Tumor; Coloring Agents; Drug Resistance, Neoplasm; Endothelial Cells; Green Fluorescent Proteins; Indoles; Macrophages; Male; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Nitroimidazoles; Prostatic Neoplasms; Pyrroles; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Salvage Therapy; Sunitinib; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2011 |
Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Female; Humans; Immunohistochemistry; Mice; Mice, SCID; Neoplasms, Experimental; Neovascularization, Pathologic; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Xenograft Model Antitumor Assays | 2012 |
HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
Topics: Carcinoma, Squamous Cell; Dimerization; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Idoxuridine; Immunohistochemistry; Ki-67 Antigen; Neovascularization, Pathologic; Nitroimidazoles; Nucleic Acid Synthesis Inhibitors; Perfusion; Transcription Factors; Treatment Outcome | 2002 |
A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Cattle; Cell Division; Chick Embryo; Chorion; Endothelial Growth Factors; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Hydroxamic Acids; Hypoxia; Imidazoles; Injections, Intraperitoneal; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Mice; Neovascularization, Pathologic; Nitro Compounds; Nitroimidazoles; Pulmonary Artery; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.
Topics: Animals; Brain; Cell Hypoxia; Glioma; Immunohistochemistry; Lipids; Microcirculation; Neovascularization, Pathologic; Nitroimidazoles; Radiation-Sensitizing Agents; Rats | 2003 |
TNP-470 promotes initial vascular sprouting in xenograft tumors.
Topics: Angiogenesis Inhibitors; Angiography; Animals; Antibiotics, Antineoplastic; Apoptosis; Capillaries; Cell Line, Tumor; Cyclohexanes; Fluorescein; Humans; Hypoxia; Immunohistochemistry; In Situ Hybridization; In Situ Nick-End Labeling; Lectins; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; O-(Chloroacetylcarbamoyl)fumagillol; Radiation-Sensitizing Agents; Sesquiterpenes; Vascular Endothelial Growth Factor A; Wilms Tumor | 2004 |
The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma.
Topics: Antigens, CD34; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cell Hypoxia; Cell Proliferation; Cyclin A; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Neoplasm Staging; Neovascularization, Pathologic; Nitroimidazoles; Platelet Endothelial Cell Adhesion Molecule-1; Radiation-Sensitizing Agents; Staining and Labeling; Urinary Bladder Neoplasms | 2004 |
Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Female; Hypoxia; Mice; Mice, Inbred C3H; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tirapazamine; Treatment Outcome; Triazines | 2005 |
Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.
Topics: Animals; Apoptosis; Bone Marrow Cells; Caspase 3; Caspases; Cell Hypoxia; Disease Progression; Flow Cytometry; Hematopoiesis; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Leukocyte Common Antigens; Mice; Multiple Myeloma; Neovascularization, Pathologic; Nitroimidazoles | 2005 |
Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Proliferation; Female; Head and Neck Neoplasms; Humans; Idoxuridine; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Nitroimidazoles; Nucleic Acid Synthesis Inhibitors; Radiation-Sensitizing Agents; Treatment Outcome | 2008 |
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.
Topics: Animals; Autoradiography; Cell Hypoxia; Female; Fluorine Radioisotopes; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iodine Radioisotopes; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Radionuclide Imaging | 2008 |
Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis.
Topics: Aged; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Carotid Stenosis; Cross-Sectional Studies; Disease Progression; Endarterectomy, Carotid; Female; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Immunohistochemistry; Macrophages; Male; Middle Aged; Neovascularization, Pathologic; Nitroimidazoles; Oxidative Stress; RNA, Messenger; Vascular Endothelial Growth Factor A | 2008 |
The paradox of hypoxic and oxidative stress in atherosclerosis.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherosclerosis; Biomarkers; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Macrophages; Neovascularization, Pathologic; Nitroimidazoles; Oxidative Stress; Reactive Oxygen Species | 2008 |
Correlative imaging of hypoxia and angiogenesis in oncology.
Topics: Autoradiography; Cell Hypoxia; Glucosides; Humans; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Positron-Emission Tomography | 2008 |
A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumour.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C3H; Misonidazole; Neovascularization, Pathologic; Nitroimidazoles; Oxygen; Phosphorus Radioisotopes | 1996 |
Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis.
Topics: Animals; Blotting, Western; Cell Hypoxia; Endothelial Growth Factors; Fibroblast Growth Factor 2; Immunohistochemistry; Ki-67 Antigen; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Lymphokines; Male; Neovascularization, Pathologic; Nitroimidazoles; Protein Isoforms; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |